Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Growth 2023-2029

Published: January 2023

No. of Pages: 97

Price:

Single User License: US $ 3660

Corporate User License: US $ 7320

Report Description
Table of Contents

Intracranial atherosclerotic disease is the progressive narrowing of the cerebral arteries within the skull (intracranial). The arteries that supply oxygen-enriched blood to the brain are the carotid arteries and the vertebral arteries. The circle of Willis is the area at the base of the brain that joins these arteries. Stenosis (narrowing) of the artery walls in intracranial atherosclerotic disease (ICAD) develops similarly to atherosclerosis of the heart: from the buildup of plaque, also known as an atherosclerotic lesion. The product in this report is Stent and PTA balloon for Treatment of ICAD.
LPI (LP Information)' newest research report, the ICAD (Intracranial Atherosclerotic Disease) Pathology Industry Forecast looks at past sales and reviews total world ICAD (Intracranial Atherosclerotic Disease) Pathology sales in 2022, providing a comprehensive analysis by region and market sector of projected ICAD (Intracranial Atherosclerotic Disease) Pathology sales for 2023 through 2029. With ICAD (Intracranial Atherosclerotic Disease) Pathology sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world ICAD (Intracranial Atherosclerotic Disease) Pathology industry.
This Insight Report provides a comprehensive analysis of the global ICAD (Intracranial Atherosclerotic Disease) Pathology landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on ICAD (Intracranial Atherosclerotic Disease) Pathology portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global ICAD (Intracranial Atherosclerotic Disease) Pathology market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for ICAD (Intracranial Atherosclerotic Disease) Pathology and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global ICAD (Intracranial Atherosclerotic Disease) Pathology.
The global ICAD (Intracranial Atherosclerotic Disease) Pathology market size is projected to grow from US$ 170.2 million in 2022 to US$ 313.7 million in 2029; it is expected to grow at a CAGR of 313.7 from 2023 to 2029.
Global ICAD (Intracranial Atherosclerotic Disease) Pathology key players include Stryker, Balt, TERUMO, MicroPort, Acandis, etc. Global top five manufacturers hold a share about 90%. Asia-Pacific is the largest market, with a share about 45%, followed by North America, with a share about 25 percent. In terms of product, Stent is the largest segment, with a share about 80%. And in terms of application, the largest application is Hospital, followed by Clinic, etc.
This report presents a comprehensive overview, market shares, and growth opportunities of ICAD (Intracranial Atherosclerotic Disease) Pathology market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
- Stent
- PTA Balloon

Segmentation by application
- Hospital
- Clinic
- Other

This report also splits the market by region:
- Americas
- - United States
- - Canada
- - Mexico
- - Brazil
- APAC
- - China
- - Japan
- - Korea
- - Southeast Asia
- - India
- - Australia
- Europe
- - Germany
- - France
- - UK
- - Italy
- - Russia
- Middle East & Africa
- - Egypt
- - South Africa
- - Israel
- - Turkey
- - GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
- Stryker
- Balt
- TERUMO
- MicroPort
- Acandis

Key Questions Addressed in this Report
What is the 10-year outlook for the global ICAD (Intracranial Atherosclerotic Disease) Pathology market?
What factors are driving ICAD (Intracranial Atherosclerotic Disease) Pathology market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do ICAD (Intracranial Atherosclerotic Disease) Pathology market opportunities vary by end market size?
How does ICAD (Intracranial Atherosclerotic Disease) Pathology break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for ICAD (Intracranial Atherosclerotic Disease) Pathology by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for ICAD (Intracranial Atherosclerotic Disease) Pathology by Country/Region, 2018, 2022 & 2029
2.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Segment by Type
2.2.1 Stent
2.2.2 PTA Balloon
2.3 ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type
2.3.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Type (2018-2023)
2.3.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Market Share by Type (2018-2023)
2.3.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sale Price by Type (2018-2023)
2.4 ICAD (Intracranial Atherosclerotic Disease) Pathology Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application
2.5.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sale Market Share by Application (2018-2023)
2.5.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Market Share by Application (2018-2023)
2.5.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sale Price by Application (2018-2023)
3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology by Company
3.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Breakdown Data by Company
3.1.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Annual Sales by Company (2018-2023)
3.1.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Company (2018-2023)
3.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Annual Revenue by Company (2018-2023)
3.2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Company (2018-2023)
3.2.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Company (2018-2023)
3.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sale Price by Company
3.4 Key Manufacturers ICAD (Intracranial Atherosclerotic Disease) Pathology Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers ICAD (Intracranial Atherosclerotic Disease) Pathology Product Location Distribution
3.4.2 Players ICAD (Intracranial Atherosclerotic Disease) Pathology Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for ICAD (Intracranial Atherosclerotic Disease) Pathology by Geographic Region
4.1 World Historic ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Geographic Region (2018-2023)
4.1.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Annual Sales by Geographic Region (2018-2023)
4.1.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Country/Region (2018-2023)
4.2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Annual Sales by Country/Region (2018-2023)
4.2.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Annual Revenue by Country/Region (2018-2023)
4.3 Americas ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Growth
4.4 APAC ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Growth
4.5 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Growth
4.6 Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Growth
5 Americas
5.1 Americas ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country
5.1.1 Americas ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2018-2023)
5.1.2 Americas ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Country (2018-2023)
5.2 Americas ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type
5.3 Americas ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Region
6.1.1 APAC ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Region (2018-2023)
6.1.2 APAC ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Region (2018-2023)
6.2 APAC ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type
6.3 APAC ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology by Country
7.1.1 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2018-2023)
7.1.2 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Country (2018-2023)
7.2 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type
7.3 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology by Country
8.1.1 Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2018-2023)
8.1.2 Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Country (2018-2023)
8.2 Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type
8.3 Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of ICAD (Intracranial Atherosclerotic Disease) Pathology
10.3 Manufacturing Process Analysis of ICAD (Intracranial Atherosclerotic Disease) Pathology
10.4 Industry Chain Structure of ICAD (Intracranial Atherosclerotic Disease) Pathology
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Distributors
11.3 ICAD (Intracranial Atherosclerotic Disease) Pathology Customer
12 World Forecast Review for ICAD (Intracranial Atherosclerotic Disease) Pathology by Geographic Region
12.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Forecast by Region
12.1.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Forecast by Region (2024-2029)
12.1.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Forecast by Type
12.7 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Forecast by Application
13 Key Players Analysis
13.1 Stryker
13.1.1 Stryker Company Information
13.1.2 Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Product Portfolios and Specifications
13.1.3 Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Stryker Main Business Overview
13.1.5 Stryker Latest Developments
13.2 Balt
13.2.1 Balt Company Information
13.2.2 Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Product Portfolios and Specifications
13.2.3 Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Balt Main Business Overview
13.2.5 Balt Latest Developments
13.3 TERUMO
13.3.1 TERUMO Company Information
13.3.2 TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Product Portfolios and Specifications
13.3.3 TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 TERUMO Main Business Overview
13.3.5 TERUMO Latest Developments
13.4 MicroPort
13.4.1 MicroPort Company Information
13.4.2 MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Product Portfolios and Specifications
13.4.3 MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 MicroPort Main Business Overview
13.4.5 MicroPort Latest Developments
13.5 Acandis
13.5.1 Acandis Company Information
13.5.2 Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Product Portfolios and Specifications
13.5.3 Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Acandis Main Business Overview
13.5.5 Acandis Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. ICAD (Intracranial Atherosclerotic Disease) Pathology Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. ICAD (Intracranial Atherosclerotic Disease) Pathology Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Stent
Table 4. Major Players of PTA Balloon
Table 5. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2018-2023) & (Units)
Table 6. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Type (2018-2023)
Table 7. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Type (2018-2023) & ($ million)
Table 8. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Type (2018-2023)
Table 9. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sale Price by Type (2018-2023) & (USD/Unit)
Table 10. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2018-2023) & (Units)
Table 11. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Application (2018-2023)
Table 12. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Application (2018-2023)
Table 13. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Application (2018-2023)
Table 14. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sale Price by Application (2018-2023) & (USD/Unit)
Table 15. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Company (2018-2023) & (Units)
Table 16. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Company (2018-2023)
Table 17. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Company (2018-2023) ($ Millions)
Table 18. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Company (2018-2023)
Table 19. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sale Price by Company (2018-2023) & (USD/Unit)
Table 20. Key Manufacturers ICAD (Intracranial Atherosclerotic Disease) Pathology Producing Area Distribution and Sales Area
Table 21. Players ICAD (Intracranial Atherosclerotic Disease) Pathology Products Offered
Table 22. ICAD (Intracranial Atherosclerotic Disease) Pathology Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Geographic Region (2018-2023) & (Units)
Table 26. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share Geographic Region (2018-2023)
Table 27. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country/Region (2018-2023) & (Units)
Table 30. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Country/Region (2018-2023)
Table 31. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2018-2023) & (Units)
Table 34. Americas ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Country (2018-2023)
Table 35. Americas ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Country (2018-2023)
Table 37. Americas ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2018-2023) & (Units)
Table 38. Americas ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2018-2023) & (Units)
Table 39. APAC ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Region (2018-2023) & (Units)
Table 40. APAC ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Region (2018-2023)
Table 41. APAC ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Region (2018-2023)
Table 43. APAC ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2018-2023) & (Units)
Table 44. APAC ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2018-2023) & (Units)
Table 45. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2018-2023) & (Units)
Table 46. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Country (2018-2023)
Table 47. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Country (2018-2023)
Table 49. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2018-2023) & (Units)
Table 50. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2018-2023) & (Units)
Table 51. Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2018-2023) & (Units)
Table 52. Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2018-2023) & (Units)
Table 56. Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2018-2023) & (Units)
Table 57. Key Market Drivers & Growth Opportunities of ICAD (Intracranial Atherosclerotic Disease) Pathology
Table 58. Key Market Challenges & Risks of ICAD (Intracranial Atherosclerotic Disease) Pathology
Table 59. Key Industry Trends of ICAD (Intracranial Atherosclerotic Disease) Pathology
Table 60. ICAD (Intracranial Atherosclerotic Disease) Pathology Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. ICAD (Intracranial Atherosclerotic Disease) Pathology Distributors List
Table 63. ICAD (Intracranial Atherosclerotic Disease) Pathology Customer List
Table 64. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Forecast by Region (2024-2029) & (Units)
Table 65. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Forecast by Country (2024-2029) & (Units)
Table 67. Americas ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Forecast by Region (2024-2029) & (Units)
Table 69. APAC ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Forecast by Country (2024-2029) & (Units)
Table 71. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Forecast by Country (2024-2029) & (Units)
Table 73. Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Forecast by Type (2024-2029) & (Units)
Table 75. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Forecast by Application (2024-2029) & (Units)
Table 77. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Stryker Basic Information, ICAD (Intracranial Atherosclerotic Disease) Pathology Manufacturing Base, Sales Area and Its Competitors
Table 79. Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Product Portfolios and Specifications
Table 80. Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 81. Stryker Main Business
Table 82. Stryker Latest Developments
Table 83. Balt Basic Information, ICAD (Intracranial Atherosclerotic Disease) Pathology Manufacturing Base, Sales Area and Its Competitors
Table 84. Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Product Portfolios and Specifications
Table 85. Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 86. Balt Main Business
Table 87. Balt Latest Developments
Table 88. TERUMO Basic Information, ICAD (Intracranial Atherosclerotic Disease) Pathology Manufacturing Base, Sales Area and Its Competitors
Table 89. TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Product Portfolios and Specifications
Table 90. TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 91. TERUMO Main Business
Table 92. TERUMO Latest Developments
Table 93. MicroPort Basic Information, ICAD (Intracranial Atherosclerotic Disease) Pathology Manufacturing Base, Sales Area and Its Competitors
Table 94. MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Product Portfolios and Specifications
Table 95. MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 96. MicroPort Main Business
Table 97. MicroPort Latest Developments
Table 98. Acandis Basic Information, ICAD (Intracranial Atherosclerotic Disease) Pathology Manufacturing Base, Sales Area and Its Competitors
Table 99. Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Product Portfolios and Specifications
Table 100. Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 101. Acandis Main Business
Table 102. Acandis Latest Developments
List of Figures
Figure 1. Picture of ICAD (Intracranial Atherosclerotic Disease) Pathology
Figure 2. ICAD (Intracranial Atherosclerotic Disease) Pathology Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Growth Rate 2018-2029 (Units)
Figure 7. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Stent
Figure 10. Product Picture of PTA Balloon
Figure 11. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Type in 2022
Figure 12. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Type (2018-2023)
Figure 13. ICAD (Intracranial Atherosclerotic Disease) Pathology Consumed in Hospital
Figure 14. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market: Hospital (2018-2023) & (Units)
Figure 15. ICAD (Intracranial Atherosclerotic Disease) Pathology Consumed in Clinic
Figure 16. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market: Clinic (2018-2023) & (Units)
Figure 17. ICAD (Intracranial Atherosclerotic Disease) Pathology Consumed in Other
Figure 18. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market: Other (2018-2023) & (Units)
Figure 19. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Application (2022)
Figure 20. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Application in 2022
Figure 21. ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market by Company in 2022 (Units)
Figure 22. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Company in 2022
Figure 23. ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market by Company in 2022 ($ Million)
Figure 24. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Company in 2022
Figure 25. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Geographic Region in 2022
Figure 27. Americas ICAD (Intracranial Atherosclerotic Disease) Pathology Sales 2018-2023 (Units)
Figure 28. Americas ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue 2018-2023 ($ Millions)
Figure 29. APAC ICAD (Intracranial Atherosclerotic Disease) Pathology Sales 2018-2023 (Units)
Figure 30. APAC ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue 2018-2023 ($ Millions)
Figure 31. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales 2018-2023 (Units)
Figure 32. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales 2018-2023 (Units)
Figure 34. Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue 2018-2023 ($ Millions)
Figure 35. Americas ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Country in 2022
Figure 36. Americas ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Country in 2022
Figure 37. Americas ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Type (2018-2023)
Figure 38. Americas ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Application (2018-2023)
Figure 39. United States ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Region in 2022
Figure 44. APAC ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Regions in 2022
Figure 45. APAC ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Type (2018-2023)
Figure 46. APAC ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Application (2018-2023)
Figure 47. China ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth 2018-2023 ($ Millions)
Figure 51. India ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Country in 2022
Figure 55. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Country in 2022
Figure 56. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Type (2018-2023)
Figure 57. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Application (2018-2023)
Figure 58. Germany ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth 2018-2023 ($ Millions)
Figure 59. France ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Country in 2022
Figure 64. Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Application (2018-2023)
Figure 67. Egypt ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of ICAD (Intracranial Atherosclerotic Disease) Pathology in 2022
Figure 73. Manufacturing Process Analysis of ICAD (Intracranial Atherosclerotic Disease) Pathology
Figure 74. Industry Chain Structure of ICAD (Intracranial Atherosclerotic Disease) Pathology
Figure 75. Channels of Distribution
Figure 76. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Forecast by Region (2024-2029)
Figure 77. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share Forecast by Application (2024-2029)

Write comment about above report:

Published By: LP Information INC

Product Code: LP Information INC319851

Related Reports

Did you find what you are/were looking for ? If not, read below and browse through other relevant pages for similar market research reports OR get in touch with us through the form/contact info in your right navigation panel and well share relevant market report titles for you to explore.

Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Research Report 2023 Intracranial atherosclerotic disease is the progressive narrowing of the cerebral arteries within the skull (intracranial). The arteries that supply oxygen-enriched blood to the brain are the carotid arteries and the vertebral arteries. The circle of...
Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Research Report 2022 - Market Size, Current Insights and Development Trends Intracranial atherosclerotic disease (ICAD) is the most common cause of stroke worldwide. It is the progressive narrowing of the cerebral arteries within the skull (intracranial). Strokes may be caused either by clots or by bleeding (hemorrhage) that...
2023-2031 Report on Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market by Player, Region, Type, Application and Sales Channel This report studies the ICAD (Intracranial Atherosclerotic Disease) Pathology market, covering market size for segment by type (ICAD Stent, PTA Balloon, etc.), by application (Hospitals, Clinics, etc.), by sales channel (Direct Channel, Distribution ...
Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Insights: Impact of COVID-19 and Future Expectations to 2028 Intracranial atherosclerotic disease (ICAD) is the most common cause of stroke worldwide. It is the progressive narrowing of the cerebral arteries within the skull (intracranial). Strokes may be caused either by clots or by bleeding (hemorrhage) that...
Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Research Report 2023 This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment market with multiple angle...
Global ICAD (Intracranial Atherosclerotic Disease Pathology) Market Insights: Impact of COVID-19 and Future Expectations to 2028 The ICAD (Intracranial Atherosclerotic Disease Pathology) market revenue was 185.41 Million USD in 2022, and will reach 343.21 Million USD in 2028, with a CAGR of 10.81% during 2022-2028. This report elaborates the market size, market ...
ICAD (Intracranial Atherosclerotic Disease) Pathology Market, Global Outlook and Forecast 2023-2029 Intracranial atherosclerotic disease is the progressive narrowing of the cerebral arteries within the skull (intracranial). The arteries that supply oxygen-enriched blood to the brain are the carotid arteries and the vertebral arteries. The circle of...
Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Insights, Forecast to 2029 Intracranial atherosclerotic disease is the progressive narrowing of the cerebral arteries within the skull (intracranial). The arteries that supply oxygen-enriched blood to the brain are the carotid arteries and the vertebral arteries. The circle of...
Global ICAD (Intracranial Atherosclerotic Disease Pathology) Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028 Market Overview of Global ICAD (Intracranial Atherosclerotic Disease Pathology) market: According to our latest research, the global ICAD (Intracranial Atherosclerotic Disease Pathology) market looks promising in the next 5 years. As of 2022, t...
Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Outlook 2022 The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segme...

We are on:

Why ReportsnReports.com?

500,000 market research reports and growing.
Top Fortune 500 Organizations trust us for research data.
24/7 support on call as well as emails.
Your Details are safe with us.
Free support for your research requirements.
Report Delivery: Email
Delivery Time:
- Upto 24 hrs - working days
- Upto 48 hrs max - weekends and public holidays

Need Help?

Name *

Email *

Phone *

Country *

Subject *

Comments *

We're Here To Help You

Request for Sample of this report